News

Stockholm, Sweden, 21 May, 2021 – Neobiomics AB and ExCEEd Orphan s.r.o. have entered an exclusive distribution agreement valid for 14 countries in Central and Eastern Europe (CEE). The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately.  Neobiomics is a Sweden-based company specialized in the area of neonatal and… Read More »Neobiomics AB and ExCEEd Orphan s.r.o. announce exclusive cooperation for Central and Eastern Europe

Stockholm, Sweden, 17 May, 2021 – Neobiomics AB and Ewopharma AG have entered an exclusive distribution agreement valid for the territory of Switzerland. The agreement includes marketing and sales of Neobiomics’ proprietary product ProPrems® and is in effect immediately. Neobiomics AB is a Sweden-based company… Read More »Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Wednesday, April 28th 2021, Neobiomics held its Annual General Meeting. For Mårten Österlund’s extensive knowledge from R&D and the pharmaceutical market, and with documented experience in successful launches of innovative products, Mårten Österlund was elected to the Neobiomics Board of Directors, in which he was also appointed Chairman. Ann-Charlotte Beckman, Kristina Magnusson Borg,… Read More »Mårten Österlund appointed as new Chairman for Neobiomics Board of Directors

We would like to welcome Vesa Loponen as our new Business Consultant in Finland. Vesa holds a healthcare diploma (registered nurse) and has also acquired the following qualifications/degrees: Diploma in Marketing (MKT), Diploma in Marketing and Communications Management (MJD) and MBA (University of Jyväskylä). In… Read More »Vesa Loponen recruited as Business Consultant